Polyomavirus BK

• Published in: The Lancet infectious diseases Vol. 3; no. 10; pp. 611 - 623
• Main Authors: Hirsch, Hans H, Steiger, Jürg
• Format: Journal Article
• Language: English
• Published: United States Elsevier Ltd 01.10.2003; Elsevier Limited
• Subjects: Antiviral Agents - therapeutic use; BK Virus; Cytology; Cytosine - analogs & derivatives; Cytosine - therapeutic use; Humans; Immunocompromised Host; Infectious diseases; Kidney Diseases - prevention & control; Kidney Transplantation; Organophosphonates; Organophosphorus Compounds - therapeutic use; Polyomavirus Infections - prevention & control; Tumor Virus Infections - prevention & control

Polyomavirus hominis 1, better known as BK virus (BKV), infects up to 90% of the general population. However, significant clinical manifestations are rare and limited to individuals with impaired immune functions. BKV has been associated with diverse entities such as haemorrhagic cystitis, ureteric...